Dr. Alan Penman is a physician with specialty training in ophthalmology, public health, epidemiology, and biostatistics. He graduated MBChB from Aberdeen University Medical School, Scotland in 1979, and received an MSc in Clinical Tropical Medicine from London University, England in 1981, an MPH from the University of Alabama (Birmingham) in 1998, and a PhD in Biostatistics from the University of Mississippi in 2008. He completed his training in ophthalmology at Aberdeen Royal Infirmary in 1989, followed by a retinal fellowship at the MRC Sickle Cell Clinic in Kingston, Jamaica from 1990-1992. As a Professor in the Departments of Preventive Medicine and Ophthalmology at the University of Mississippi Medical Center (UMMC), Dr. Penman consults regularly with investigators conducting clinical studies and population research. In addition, he directs and teaches courses in epidemiology, biostatistics, public health and disease prevention for medical students and graduate medical faculty.Dr. Kimberly Crowder is Professor and Chair of the Department of Ophthalmology at theUniversity of Mississippi Medical Center. She completed her ophthalmology residency at UMMC in 2003, joining the department's faculty immediately afterward, and serving as the program director for the Medical Center's ophthalmology residents from 2007-2015. She was promoted to department chair in 2015. Dr. Crowder's motivation stems from her desire to improve ophthalmology education for residents and students. Since 2003, she has been an active attending physician in ophthalmology and filled multiple roles including course director for medical student electives in ophthalmology, course director of Family and Emergency Medicine resident rotations in ophthalmology, and director for the resident eye clinic. She has twice been named "Ophthalmology Faculty of the year" by the UMMC Ophthalmology residents. Dr. Crowder is board certified by the American Board ofOphthalmology and practices comprehensive ophthalmology. She's a member of a number of professional societies, among them the American Academy of Ophthalmology, for which she is currently serving on a Residency education task force. She is also a member of the Association of American Medical Colleges' Council of Faculty and Academic Societies, as well as the Mississippi Academy of Eye Physicians and Surgeons, and the Association for Research in Vision and Ophthalmology.

• 1. Effectiveness of Histocompatibility Matching in High-Risk Corneal Transplantation2. Topical Corticosteroids for Herpes Simplex Stromal Keratitis3. Topical Corticosteroids for Bacterial Keratitis4. Topical Natamycin versus Voriconazole for Fungal Corneal Ulcer5. Prevalence of Age-Related Lens Opacities in a Population6. Risk Factors for Cataract7. High-Dose Supplementation with Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss8. Routine Preoperative Medical Testing Before Cataract Surgery.9. Prophylaxis of Postoperative Endophthalmitis Following Cataract Surgery10. The Relationship Between Optic Disc Area and Open-Angle Glaucoma11. Is argon laser trabeculoplasty equivalent to topical medication as an initial treatment for primary open-angle glaucoma?12. Intraocular Pressure Reduction in the Treatment of Normal-Tension Glaucoma13. The Relationship Between Control of Intraocular Pressure after Surgical Intervention for Glaucoma and Visual Field Deterioration14. Reduction of intraocular pressure and glaucoma progression15. Topical ocular hypotensive medication to delay or prevent the onset of primary open-angle glaucoma16. Intraocular Pressure Control and Long-Term Visual Field Loss in Open-Angle Glaucoma17. Latanoprost for Open-Angle Glaucoma18. Tube Shunt Surgery Versus Trabeculectomy in Eyes with Prior Ocular Surgery and Uncontrolled Glaucoma19. Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study20. Risk Factors for Branch and Central Retinal Vein Occlusion21. Argon Laser Photocoagulation for Macular Edema in Branch Vein Occlusion22. Intraocular Injections of Ranibizumab in Patients With Macular Edema Following Branch Retinal Vein Occlusion23. Grid Pattern Photocoagulation for Macular Edema in Central Vein Occlusion24. Steroids in the Treatment of Central Retinal Vein Occlusion25. Cryotherapy for Retinopathy of Prematurity26. Supplemental Therapeutic Oxygen for Pre-Threshold Retinopathy of Prematurity27. Early Treatment of Prethreshold Retinopathy of Prematurity 28. Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity 29. Photocoagulation for Diabetic Macular Edema30. Early Photocoagulation for Diabetic Retinopathy 31. Does Pars Plana Vitrectomy Improve Visual Outcomes in Patients with Complications of Proliferative Diabetic Retinopathy32. Intensive Diabetes Management to Reduce the Risk of Retinopathy Developing or Progressing 33. Progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus 34. Immediate Vitrectomy and Intravenous Antibiotics for the Treatment of Postoperative Bacterial Endophthalmitis35. Prevalence of Age-Related Maculopathy 36. Does high-dose supplementation with vitamins C and E, beta carotene, and zinc slow the progression of age-related macular degeneration and vision loss?37. Argon laser photocoagulation for extrafoveal neovascular maculopathy 38. Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration with Verteporfin 39. Pegaptanib for Neovascular Age-Related Macular Degeneration40. Ranibizumab for Neovascular Age-Related Macular Degeneration41. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration 42. Effect of Pre-Enucleation Radiation on Mortality in Large Choroidal Melanomas 43. Systemic Anti-Inflammatory Therapy versus Fluocinolone Acetonide 44. Botulinum A Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery45. Botulinum A Toxin Injection as a Treatment for Blepharospasm46. A Clinical Activity Score That Discriminates Between Inflammatory and Non-Inflammatory Graves' Ophthalmopathy47. Corticosteroids in the Treatment of Acute Optic Neuritis48. Atropine or Patching for Treatment of Moderate Amblyopia in Children 49. Contact Lens vs Intraocular Lens Correction of Monocular Aphakia During Infancy 50. Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss

Dr. Alan Penman is a physician with specialty training in ophthalmology, public health, epidemiology, and biostatistics. He graduated MBChB from Aberdeen University Medical School, Scotland in 1979, and received an MSc in Clinical Tropical Medicine from London University, England in 1981, an MPH from the University of Alabama (Birmingham) in 1998, and a PhD in Biostatistics from the University of Mississippi in 2008. He completed his training in ophthalmology at Aberdeen Royal Infirmary in 1989, followed by a retinal fellowship at the MRC Sickle Cell Clinic in Kingston, Jamaica from 1990-1992. As a Professor in the Departments of Preventive Medicine and Ophthalmology at the University of Mississippi Medical Center (UMMC), Dr. Penman consults regularly with investigators conducting clinical studies and population research. In addition, he directs and teaches courses in epidemiology, biostatistics, public health and disease prevention for medical students and graduate medical faculty.Dr. Kimberly Crowder is Professor and Chair of the Department of Ophthalmology at theUniversity of Mississippi Medical Center. She completed her ophthalmology residency at UMMC in 2003, joining the department's faculty immediately afterward, and serving as the program director for the Medical Center's ophthalmology residents from 2007-2015. She was promoted to department chair in 2015. Dr. Crowder's motivation stems from her desire to improve ophthalmology education for residents and students. Since 2003, she has been an active attending physician in ophthalmology and filled multiple roles including course director for medical student electives in ophthalmology, course director of Family and Emergency Medicine resident rotations in ophthalmology, and director for the resident eye clinic. She has twice been named "Ophthalmology Faculty of the year" by the UMMC Ophthalmology residents. Dr. Crowder is board certified by the American Board ofOphthalmology and practices comprehensive ophthalmology. She's a member of a number of professional societies, among them the American Academy of Ophthalmology, for which she is currently serving on a Residency education task force. She is also a member of the Association of American Medical Colleges' Council of Faculty and Academic Societies, as well as the Mississippi Academy of Eye Physicians and Surgeons, and the Association for Research in Vision and Ophthalmology.

• 1. Effectiveness of Histocompatibility Matching in High-Risk Corneal Transplantation2. Topical Corticosteroids for Herpes Simplex Stromal Keratitis3. Topical Corticosteroids for Bacterial Keratitis4. Topical Natamycin versus Voriconazole for Fungal Corneal Ulcer5. Prevalence of Age-Related Lens Opacities in a Population6. Risk Factors for Cataract7. High-Dose Supplementation with Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss8. Routine Preoperative Medical Testing Before Cataract Surgery.9. Prophylaxis of Postoperative Endophthalmitis Following Cataract Surgery10. The Relationship Between Optic Disc Area and Open-Angle Glaucoma11. Is argon laser trabeculoplasty equivalent to topical medication as an initial treatment for primary open-angle glaucoma?12. Intraocular Pressure Reduction in the Treatment of Normal-Tension Glaucoma13. The Relationship Between Control of Intraocular Pressure after Surgical Intervention for Glaucoma and Visual Field Deterioration14. Reduction of intraocular pressure and glaucoma progression15. Topical ocular hypotensive medication to delay or prevent the onset of primary open-angle glaucoma16. Intraocular Pressure Control and Long-Term Visual Field Loss in Open-Angle Glaucoma17. Latanoprost for Open-Angle Glaucoma18. Tube Shunt Surgery Versus Trabeculectomy in Eyes with Prior Ocular Surgery and Uncontrolled Glaucoma19. Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study20. Risk Factors for Branch and Central Retinal Vein Occlusion21. Argon Laser Photocoagulation for Macular Edema in Branch Vein Occlusion22. Intraocular Injections of Ranibizumab in Patients With Macular Edema Following Branch Retinal Vein Occlusion23. Grid Pattern Photocoagulation for Macular Edema in Central Vein Occlusion24. Steroids in the Treatment of Central Retinal Vein Occlusion25. Cryotherapy for Retinopathy of Prematurity26. Supplemental Therapeutic Oxygen for Pre-Threshold Retinopathy of Prematurity27. Early Treatment of Prethreshold Retinopathy of Prematurity 28. Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity 29. Photocoagulation for Diabetic Macular Edema30. Early Photocoagulation for Diabetic Retinopathy 31. Does Pars Plana Vitrectomy Improve Visual Outcomes in Patients with Complications of Proliferative Diabetic Retinopathy32. Intensive Diabetes Management to Reduce the Risk of Retinopathy Developing or Progressing 33. Progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus 34. Immediate Vitrectomy and Intravenous Antibiotics for the Treatment of Postoperative Bacterial Endophthalmitis35. Prevalence of Age-Related Maculopathy 36. Does high-dose supplementation with vitamins C and E, beta carotene, and zinc slow the progression of age-related macular degeneration and vision loss?37. Argon laser photocoagulation for extrafoveal neovascular maculopathy 38. Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration with Verteporfin 39. Pegaptanib for Neovascular Age-Related Macular Degeneration40. Ranibizumab for Neovascular Age-Related Macular Degeneration41. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration 42. Effect of Pre-Enucleation Radiation on Mortality in Large Choroidal Melanomas 43. Systemic Anti-Inflammatory Therapy versus Fluocinolone Acetonide 44. Botulinum A Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery45. Botulinum A Toxin Injection as a Treatment for Blepharospasm46. A Clinical Activity Score That Discriminates Between Inflammatory and Non-Inflammatory Graves' Ophthalmopathy47. Corticosteroids in the Treatment of Acute Optic Neuritis48. Atropine or Patching for Treatment of Moderate Amblyopia in Children 49. Contact Lens vs Intraocular Lens Correction of Monocular Aphakia During Infancy 50. Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss